| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/07/1995 | CA2129565A1 Oligonucleotide compounds, their production and use |
| 02/02/1995 | WO1995003432A1 Linked linear amplification of nucleic acids |
| 02/02/1995 | WO1995003422A1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 02/02/1995 | WO1995003409A1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 02/02/1995 | WO1995003408A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | WO1995003406A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | WO1995003401A1 Method for screening unknown organisms |
| 02/02/1995 | WO1995003335A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | WO1995003333A2 Tryptase inhibitor |
| 02/02/1995 | WO1995003328A2 Melanoma-inhibiting protein |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003318A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | WO1995003296A1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives |
| 02/02/1995 | WO1994029446A3 Intracellular binding proteins and use thereof |
| 02/02/1995 | WO1994029316A3 Texaphyrin metal complex mediated ester hydrolysis |
| 02/02/1995 | WO1994028129A3 Tumour metastasis gene |
| 02/02/1995 | CA2168232A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | CA2168096A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | CA2167840A1 Linked linear amplification of nucleic acids |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2167091A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | CA2166890A1 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | CA2166782A1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives |
| 02/02/1995 | CA2164221A1 Tryptase inhibitor |
| 02/01/1995 | EP0636187A1 NUCLEOTIDIC SEQUENCES HYBRIDIZING SPECIFICALLY WITH A $i(CAMPYLOBACTER JEJUNI) GENOMIC NUCLEIC SEQUENCE |
| 02/01/1995 | EP0636177A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN $g(b) SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E |
| 02/01/1995 | EP0636176A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 02/01/1995 | EP0635998A1 Method and composition for inhibition of viral replication |
| 02/01/1995 | CN1098140A Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 02/01/1995 | CN1098107A Modified oligodeoxyribonucleotides, their preparation and their therapeutic use |
| 01/31/1995 | US5386025 Calcium channel compositions and methods |
| 01/31/1995 | US5386024 Method to prepare nucleic acids from a biological sample using low pH and acid protease |
| 01/31/1995 | US5386023 Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling |
| 01/31/1995 | US5386020 Branched oligonucloetides having double-stranded projections bonded to each other to yield frame for use in immobilizing other macromolecules |
| 01/31/1995 | CA1334174C 2- and 8-azido (2'-5')oligoadenylates and antiviral uses thereof |
| 01/30/1995 | CA2126523A1 Jak kinases and regulation of cytokine signal transduction |
| 01/26/1995 | WO1995002704A2 Poliovirus specific primers and methods of detection utilizing the same |
| 01/26/1995 | WO1995002684A1 Regulated apoptosis |
| 01/26/1995 | WO1995002422A1 Method for conjugating nucleotides and nucleosides to disulfide-, maleimide-, and thiol-containing compounds |
| 01/26/1995 | WO1994028125A3 Dna encoding prostaglandin receptor ep1 |
| 01/26/1995 | CA2167282A1 Regulated apoptosis |
| 01/26/1995 | CA2167209A1 Poliovirus specific primers and method of detection utilizing the same |
| 01/25/1995 | EP0635068A1 Amplification of human mdm2 gene in human tumors |
| 01/25/1995 | EP0635060A1 Myogenic vector systems |
| 01/25/1995 | EP0635054A1 Mammalian melanocyte stimulating hormone receptors and uses |
| 01/25/1995 | EP0635023A1 Covalently cross-linked oligonucleotides |
| 01/25/1995 | EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression |
| 01/24/1995 | US5384261 Channel blocking on rotating stage, treatment with light |
| 01/24/1995 | US5384241 Specific binding assay compound with inhibitive self-quenching characteristics |
| 01/19/1995 | WO1995002069A1 Oligonucleotide modulation of protein kinase c |
| 01/19/1995 | WO1995002057A1 Protein tyrosine kinase and ligands thereof |
| 01/19/1995 | WO1995002054A2 Platelet glycoprotein v gene and uses |
| 01/19/1995 | WO1995002052A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein |
| 01/19/1995 | WO1995002051A2 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms |
| 01/19/1995 | WO1995001987A1 Process for solid support nucleic acid synthesis and compounds useful as solid supports in said process |
| 01/19/1995 | WO1995001986A1 Dideoxyfructonucleotides and deoxyfructonucleotides as dna polymerase substrates |
| 01/19/1995 | WO1995001985A1 Auto-ligating oligonucleotide antisense compounds having diagnostic and therapeutic applications |
| 01/19/1995 | WO1995001802A1 Growth differentiation factor-7 |
| 01/19/1995 | WO1995001801A1 Growth differentiation factor-6 |
| 01/19/1995 | WO1994026891A3 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 01/19/1995 | CA2166872A1 Platelet glycoprotein v gene and uses |
| 01/19/1995 | CA2166765A1 Process for solid support nucleic acid synthesis and compounds useful as solid supports in said process |
| 01/19/1995 | CA2166058A1 Oligonucleotide modulation of protein kinase c |
| 01/19/1995 | CA2165778A1 Growth differentiation factor-7 |
| 01/19/1995 | CA2165776A1 Growth differentiation factor-6 |
| 01/19/1995 | CA2141417A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein |
| 01/18/1995 | EP0633932A1 DELIGNIFYING PREPARATION EXHIBITING $g(a)-L-ARABINOFURANOSIDASE ACTIVITY, PRODUCTION AND APPLICATION THEREOF |
| 01/18/1995 | EP0633891A1 Synthesis of oligonucleotides. |
| 01/18/1995 | EP0633890A1 Support for oligonucleotide synthesis |
| 01/18/1995 | EP0549686A4 Modified internucleoside linkages |
| 01/17/1995 | US5382521 Detection of cancer cells |
| 01/17/1995 | US5382509 Method and kit for the diagnosis of human papillomavirus type 41 |
| 01/17/1995 | US5382438 Preparation of yogurt with lac(-) L. bulgaricus |
| 01/12/1995 | WO1995001456A1 Oligonucleotide clamps having diagnostic and therapeutic applications |
| 01/12/1995 | WO1995001454A1 Method for detection of susceptibility mutations for ototoxic deafness |
| 01/12/1995 | WO1995001447A1 Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells |
| 01/12/1995 | WO1995001445A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
| 01/12/1995 | WO1995001437A2 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
| 01/12/1995 | WO1995001434A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | WO1995001370A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | WO1995001369A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | WO1995001365A1 Synthesis of branched nucleic acids |
| 01/12/1995 | WO1995001364A1 Chemically modified oligonucleotide for site-directed mutagenesis |
| 01/12/1995 | WO1995001363A1 Methylphosphonic acid ester, process for preparing the same and its use |
| 01/12/1995 | WO1995001359A1 Chromatographic purification and separation process for mixtures of nucleic acids |
| 01/12/1995 | WO1994025595A3 Cytolysin gene and gene product |
| 01/12/1995 | CA2166462A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | CA2166461A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | CA2166401A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
| 01/12/1995 | CA2166278A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | CA2143620A1 Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells |
| 01/11/1995 | EP0633313A1 Vaccine against lyme disease |
| 01/11/1995 | EP0633028A1 Vaccine against lyme disease |
| 01/11/1995 | EP0632833A1 Compositions and methods for pace 4 and 4.1 gene and polypeptides in cells |
| 01/11/1995 | EP0632814A1 High molecular weight surface proteines of non-typeable haemophilus |
| 01/11/1995 | EP0632722A1 A dna transporter system and method of use |
| 01/10/1995 | US5380835 Chemically phosphorylating the 5'-hydroxyl terminus of an oligonucleotide |